Stop smoking now, the smoking cessation pill Chantix is now avaialble to buy online.
Buy the popular and highly succsesful cessation pill here. Chantix, is a prescription medication for the treatment of smoking addiction. Chantix is a smoking cessation drug which acts similar to nicotine on the brain, reducing cravings, for cigarrettes and tabacco.
Chantix was approved for sale in The USA in May 2006. Pfizer the company that manufactures Chantix, introduced the drug for sale in the United States in September 2006. Its approval for sale in Europe soon followed under the name Champix
Buy Chantix Here
Chantix is twice as effective as Zyban (bupropion). According to a report in Journal of the American Medical Association, Chantix could be four times as effective in helping a smoker give up successfully.
Filed under Blog by admin
The health threat to city dwellers posed by Southern California wildfires like those of November 2008 may have been underestimated by officials.
Detailed particulate analysis of the smoke produced by previous California wild fires indicates that the composition posed more serious potential threats to health than is generally realized, according to a new paper analyzing particulate matter (PM) from wildfires in Southern California.
The paper, entitled “Physicochemical and Toxicological Profile of Particulate Matter (PM) in Los Angeles during the October 2007 Southern California Wildfires,” will appear in Environmental Science and Technology. It confirms earlier studies by air polllution specialist Constantinos Sioutas of the USC Viterbi School of Engineering, who is also co-director of the Southern California Particle Center.
For the study Sioutas and colleagues from USC, the University of Wisconsin-Madison and RIVM (the National Institute of Health and the Environment of the Netherlands) analyzed the particular matter gathered during the fall 2007 blazes.
The health threat to city dwellers posed by Southern California wildfires like those of November 2008 may have been underestimated by officials.
Detailed particulate analysis of the smoke produced by previous California wild fires indicates that the composition posed more serious potential threats to health than is generally realized, according to a new paper analyzing particulate matter (PM) from wildfires in Southern California.
The paper, entitled “Physicochemical and Toxicological Profile of Particulate Matter (PM) in Los Angeles during the October 2007 Southern California Wildfires,” will appear in Environmental Science and Technology. It confirms earlier studies by air polllution specialist Constantinos Sioutas of the USC Viterbi School of Engineering, who is also co-director of the Southern California Particle Center.
For the study Sioutas and colleagues from USC, the University of Wisconsin-Madison and RIVM (the National Institute of Health and the Environment of the Netherlands) analyzed the particular matter gathered during the fall 2007 blazes.
Individuals who were underweight at birth are at increased risk of developing a condition called secondary focal segmental glomerulosclerosis, according to a study appearing in the January 2009 issue of the Clinical Journal of the American Society Nephrology (CJASN). Because birth history is often overlooked by kidney specialists who take care of adult patients, this risk factor is likely to be under-recognized.
Patients with focal segmental glomerulosclerosis develop scarring of glomeruli, the filtering units of the kidney. This development can cause a decline in kidney function and leakage of protein into the urine.
Low birth weight (less than 5.5 pounds) caused by prematurity or slow growth prior to birth is a risk factor for adult hypertension, coronary heart disease, stroke, diabetes, and other diseases. However, its association with the development of focal segmental glomerulosclerosis has not been reported.
Individuals who were underweight at birth are at increased risk of developing a condition called secondary focal segmental glomerulosclerosis, according to a study appearing in the January 2009 issue of the Clinical Journal of the American Society Nephrology (CJASN). Because birth history is often overlooked by kidney specialists who take care of adult patients, this risk factor is likely to be under-recognized.
Patients with focal segmental glomerulosclerosis develop scarring of glomeruli, the filtering units of the kidney. This development can cause a decline in kidney function and leakage of protein into the urine.
Low birth weight (less than 5.5 pounds) caused by prematurity or slow growth prior to birth is a risk factor for adult hypertension, coronary heart disease, stroke, diabetes, and other diseases. However, its association with the development of focal segmental glomerulosclerosis has not been reported.
Acupuncture is already a renowned method used in treating smoking addiction. An alternative medicine believed to have originated as far as 3000 BC in ancient China, this treatment is now being widely utilized for various medicinal and therapeutic purposes. It has been found furthermore to successfully treat drug dependence and help people stop smoking.
There are several smoking cessation medications and therapies available presently. However acupuncture is a recommended alternative procedure, especially where conventional therapies have already failed.
The strategic insertion of needles in various parts of the body aims to treat the condition in a more profound and emotional level. A smoker needs to free himself from the physiological and psychological addiction of smoking, thus necessitating a more holistic treatment.
How It Stops the Addiction
The placement of needles is usually located behind the ear, or on the ear cartilage. This is where the calming effect takes place, curbing the patient’s cravings for more cigarettes.
(more…)
Tags:
Ways to Quit Smoking
Today is the day that thousands of Americans across the United States have chosen to begin their journey to freedom from nicotine addiction. If you're here looking for help…
Scientists have identified a promising set of new compounds in the fight against muscular dystrophy.
Using a drug-discovery technique in which molecules compete against each other for access to the target – the strand of toxic RNA that causes the most common form of muscular dystrophy in adults – a team at the University of Rochester Medical Center has identified several compounds that, in the laboratory, block the unwanted coupling of two molecules that is at the root of the disease.
The work was published online November 7 by the Journal of the American Chemical Society.
“This discovery gives us, for the first time, a molecule that targets the wayward RNA at the root of myotonic muscular dystrophy,” said Benjamin Miller, Ph.D., the chemist who led the study. “This is a first step toward developing a drug-like molecule that perhaps could be used someday to treat the disease. This lead molecule provides a framework for moving forward.”
Scientists have identified a promising set of new compounds in the fight against muscular dystrophy.
Using a drug-discovery technique in which molecules compete against each other for access to the target – the strand of toxic RNA that causes the most common form of muscular dystrophy in adults – a team at the University of Rochester Medical Center has identified several compounds that, in the laboratory, block the unwanted coupling of two molecules that is at the root of the disease.
The work was published online November 7 by the Journal of the American Chemical Society.
“This discovery gives us, for the first time, a molecule that targets the wayward RNA at the root of myotonic muscular dystrophy,” said Benjamin Miller, Ph.D., the chemist who led the study. “This is a first step toward developing a drug-like molecule that perhaps could be used someday to treat the disease. This lead molecule provides a framework for moving forward.”
The more research they do, the more evidence Ohio State University scientists find that specific elements of marijuana can be good for the aging brain by reducing inflammation there and possibly even stimulating the formation of new brain cells.
The research suggests that the development of a legal drug that contains certain properties similar to those in marijuana might help prevent or delay the onset of Alzheimer’s disease. Though the exact cause of Alzheimer’s remains unknown, chronic inflammation in the brain is believed to contribute to memory impairment.
Any new drug’s properties would resemble those of tetrahydrocannabinol, or THC, the main psychoactive substance in the cannabis plant, but would not share its high-producing effects. THC joins nicotine, alcohol and caffeine as agents that, in moderation, have shown some protection against inflammation in the brain that might translate to better memory late in life.